Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 48 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 10308617

    Triazole benzamide derivatives and the compositions and methods of treatment regarding the same

    AN2H DISCOVERY LIMITED · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  2. US 10307410

    Mcl-1 modulating compounds for cancer treatment

    INSTITUT DE CANCEROLOGIE DE L'OUEST RENE GAUDUCHEAU · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  3. US 10307469

    Synthetic methylmalonyl-CoA mutase transgene for the treatment of MUT class methylmalonic acidemia (MMA)

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  4. US 10307418

    Azole pharmaceutical formulations for parenteral administration and methods for preparing and using the same as treatment of diseases sensitive to azole compounds

    Platform Brightworks Two, Ltd. · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  5. US 10307388

    Compositions and methods for diagnosis and treatment of inflammation

    United States of America as represented by the Secretary of the Air Force · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  6. US 10300047

    Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid for the treatment of disease

    PTC THERAPEUTICS, INC. · Granted May 28, 2019 · Expires May 23, 2039

    granted

  7. US 10301314

    Compounds and methods for the prevention and treatment of tumor metastasis and tumorigenesis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 28, 2019 · Expires May 23, 2039

    granted

  8. US 2019153441

    MATERIALS AND METHODS FOR TREATMENT OF AUTOSOMAL DOMINANT RETINITIS PIGMENTOSA

    CASEBIA THERAPEUTICS LLP [GB] · Granted May 23, 2019 · Expires May 18, 2039

    granted

  9. US 10293056

    Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases

    The Board of Regents of the University of Texas System · Granted May 21, 2019 · Expires May 16, 2039

    granted

  10. US 10293000

    Methods and compositions for the treatment of lysosomal storage diseases

    Sangamo Therapeutics, Inc. · Granted May 21, 2019 · Expires May 16, 2039

    granted

  11. US 10294296

    Treatment for neoplastic diseases

    XBIOTECH INC. · Granted May 21, 2019 · Expires May 16, 2039

    granted

  12. US 10286036

    Protocol for treatment of lupus nephritis

    AURINIA PHARMACEUTICALS INC. · Granted May 14, 2019 · Expires May 9, 2039

    granted

  13. US 10285935

    Non-invasive method for direct delivery of therapeutics to the spinal cord in the treatment of spinal cord pathology

    United States Department of Veteran Affairs · Granted May 14, 2019 · Expires May 9, 2039

    granted

  14. US 10285952

    Nanoparticles leverage biological membranes to target pathogens for disease treatment and diagnosis

    The Regents of the University of California · Granted May 14, 2019 · Expires May 9, 2039

    granted

  15. US 10285988

    Compounds for treatment of fibrosis diseases

    Curegenix, Inc. · Granted May 14, 2019 · Expires May 9, 2039

    granted

  16. US 10285980

    Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease

    PTC THERAPEUTICS, INC. · Granted May 14, 2019 · Expires May 9, 2039

    granted

  17. US 10280160

    Phthalazinone compounds and methods for the treatment of cystic fibrosis

    Flatley Discovery Lab, LLC · Granted May 7, 2019 · Expires May 2, 2039

    granted

  18. US 10273281

    CD80 extracellular domain polypeptides and their use in cancer treatment

    Five Prime Therapeutics, Inc. · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  19. US 10272084

    Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induced peripheral neuropathy

    The Board of Regents of the University of Texas System · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  20. US 10273245

    1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases

    Takeda Pharmaceutical Company Limited · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  21. US 10272037

    Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract

    The Regents of the University of California · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  22. US 10265329

    Altering steroid metabolism for treatment of steroid-dependent disease

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  23. US 10265337

    Use of A3 adenosine receptor agonist in osteoarthritis treatment

    CAN-FITE BIOPHARMA LTD. · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  24. US 10265313

    Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.